If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Oxford Road, Manchester M13 9PT, United KingdomFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom
Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Oxford Road, Manchester M13 9PT, United KingdomFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom
Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Oxford Road, Manchester M13 9PT, United KingdomFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom
Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Oxford Road, Manchester M13 9PT, United KingdomFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom
CIC biomaGUNE, 20009 Donostia-San Sebastian, SpainDepartment of Molecular Chemistry, University Grenoble Alpes and CNRS, 38000 Grenoble, FranceMax Planck Institute for Intelligent Systems, 70569 Stuttgart, Germany
To whom correspondence should be addressed: Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Oxford Rd., Manchester M13 9PT, United Kingdom. Tel.: 44-161-2751495; Fax: 44-161-275-5082
Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Oxford Road, Manchester M13 9PT, United KingdomFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom
* This work was supported by
Arthritis Research Campaign
Grants
14871, 18472, and 19489 and
Medical Research Council
Grant
G0701180. The authors declare that they have no conflicts of interest with the contents of this article. 1 Supported by a Biotechnology and Biological Sciences Research Council CASE award.
The matrix polysaccharide hyaluronan (HA) has a critical role in the expansion of the cumulus cell-oocyte complex (COC), a process that is necessary for ovulation and fertilization in most mammals. Hyaluronan is organized into a cross-linked network by the cooperative action of three proteins, inter-α-inhibitor (IαI), pentraxin-3, and TNF-stimulated gene-6 (TSG-6), driving the expansion of the COC and providing the cumulus matrix with its required viscoelastic properties. Although it is known that matrix stabilization involves the TSG-6-mediated transfer of IαI heavy chains (HCs) onto hyaluronan (to form covalent HC·HA complexes that are cross-linked by pentraxin-3) and that this occurs via the formation of covalent HC·TSG-6 intermediates, the underlying molecular mechanisms are not well understood. Here, we have determined the tertiary structure of the CUB module from human TSG-6, identifying a calcium ion-binding site and chelating glutamic acid residue that mediate the formation of HC·TSG-6. This occurs via an initial metal ion-dependent, non-covalent, interaction between TSG-6 and HCs that also requires the presence of an HC-associated magnesium ion. In addition, we have found that the well characterized hyaluronan-binding site in the TSG-6 Link module is not used for recognition during transfer of HCs onto HA. Analysis of TSG-6 mutants (with impaired transferase and/or hyaluronan-binding functions) revealed that although the TSG-6-mediated formation of HC·HA complexes is essential for the expansion of mouse COCs in vitro, the hyaluronan-binding function of TSG-6 does not play a major role in the stabilization of the murine cumulus matrix.
In the majority of mammals, ovulation is immediately preceded by the formation of a viscoelastic extracellular matrix by the cumulus cells that surround the oocyte (
CUB module and C-terminal peptide from human TSG-6
HA
hyaluronan
bHA10
HA decasaccharide biotinylated at the reducing end
HC
heavy chain
rHC1 and rHC2
recombinant HC1 and HC2, respectively
rhTSG-6
recombinant human TSG-6
HC·HA
hyaluronan with heavy chains covalently attached
HC·TSG-6
covalent complex of TSG-6 and a heavy chain
IαI
inter-α-inhibitor
Link_TSG6
recombinant Link module from human TSG-6
SPR
surface plasmon resonance
Tricine
N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine
MIDAS
metal ion-dependent adhesion site.
protecting the COC during its expulsion from the follicle, allowing its pickup and transport by the oviduct and providing a large surface area that facilitates sperm capture in vivo (
). The high molecular weight polysaccharide hyaluronan (HA) is a key structural component of the cumulus matrix; this non-sulfated glycosaminoglycan, composed entirely of repeating disaccharides of glucuronic acid and N-acetyl glucosamine, is organized into a cross-linked network during cumulus expansion, providing stability and the required mechanical properties of the COC (
Synthesis and accumulation of hyaluronic acid and proteoglycans in the mouse cumulus cell-oocyte during follicle stimulating hormone-induced mucification.
Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix: a role for a member of the inter-α-trypsin inhibitor family.
). There is compelling evidence that this HA-rich matrix is stabilized through the cooperative action of inter-α-inhibitor (IαI), pentraxin-3, and TSG-6 (TNF-stimulated gene-6) (
), because functional depletion/inhibition of any one of them greatly impairs COC expansion, leading to female infertility. Recent biophysical analysis has also demonstrated that human IαI, pentraxin-3, and TSG-6 are sufficient for the formation of a cross-linked matrix in model HA films (
Coding sequence, exon-intron structure and chromosomal localization of murine TNF-stimulated gene 6 that is specifically expressed by expanding cumulus cell-oocyte complexes.
IαI is composed of three protein chains (bikinun, heavy chain 1 (HC1), and HC2) that are held together covalently by a chondroitin sulfate (CS) chain (
Analysis of inter-α-trypsin inhibitor and a novel trypsin inhibitor, pre-α-trypsin inhibitor, from human plasma; polypeptide chain stoichiometry and assembly by glycan.
Organization of the inter-α-inhibitor heavy chains on the chondroitin sulfate originating from Ser10 of bikunin: posttranslational modification of IαI-derived bikunin.
), is attached to bikunin via a standard glycosaminoglycan linkage, and the HCs are attached to this proteoglycan via ester bonds between their C-terminal aspartic acid residues and C6-hydroxylates of N-acetyl galactosamine sugars of the CS chain (
). Importantly, both HC1 and HC2 of IαI can be covalently transferred onto the C6-hydroxyls of the N-acetyl glucosamine sugars in HA to form HC·HA, which are sometimes referred to as SHAP-HA (
Molecular heterogeneity of the SHAP-hyaluronan complex: isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis.
), is essential for ovulation/fertilization; deletion of the bikunin gene, which abolishes the biosynthesis of IαI and consequently the production of HC·HA, leads to a lack of cumulus expansion and greatly impaired fertility in mice (
); pentraxin-3 is an octameric protein composed of eight identical subunits (connected by disulfide bonds) through which it may bind simultaneously to multiple HCs linking HC·HA complexes together (
TSG-6 is a 35-kDa (single chain) protein composed mainly of contiguous Link and CUB modules that are flanked by N- and C-terminal sequences of 18 and 29 amino acids, respectively (
A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44.
). It has been found to be crucial in the formation of HC·HA, and the COCs from TSG-6−/− mice (that failed to expand) contained no detectable HC·HA complexes (
). TSG-6 was shown to play a direct role in the transfer of HCs from IαI onto HA via the formation of covalent intermediates (HC1·TSG-6 and HC2·TSG-6) and act as a catalyst in this process (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
); free HCs are unable to form these complexes with TSG-6 (or its individual domains) because this requires the presence of ester bonds connecting HCs to the CS chain of bikunin that are made during the biosynthesis of IαI (see Ref.
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
). However, beyond this, the molecular bases of HC·TSG-6 complex formation and HC transfer onto HA are not particularly well understood. It is known that these processes are divalent cation-dependent, but there is a lack of consensus on the identity of metal ions required and their locations within the IαI and TSG-6 proteins (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
Characterization of the interaction between tumor necrosis factor-stimulated gene-6 and heparin: implications for the inhibition of plasmin in extracellular matrix microenvironments.
TSG-6 also binds directly to pentraxin-3 using a site on the Link module that does not overlap with its HA-binding surface, leading to the hypothesis that pentraxin-3-TSG-6 complexes could cross-link HA chains (
), it has not been ruled out that TSG-6 can play a direct structural role in the organization of the cumulus matrix via its HA-binding properties (see Refs.
Two distinct populations of tumor necrosis factor stimulated gene-6 protein in the extracellular matrix of expanded mouse cumulus-cell oocyte complexes.
It is worthy of mention that HC·HA complexes are also formed in contexts other than ovulation and that, at present, TSG-6 is the only known transferase that can mediate their production. Most likely this is an ancient process in vertebrates, which predates cumulus expansion (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
Molecular heterogeneity of the SHAP-hyaluronan complex: isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis.
Biochemical characterization and function of complexes formed between hyaluronan and the heavy chains of inter-α-inhibitor (HC·HA) purified from extracts of human amniotic membrane.
). The precise activity of HC·HA complexes (and whether they are protective or pathological) will probably depend on their exact composition (e.g. number and type of HCs, size of HA, etc.) and the identity of other associated structural/signaling molecules (
Here we report the tertiary structure of the CUB module from human TSG-6 and the determination of its role in HC transfer. We have also clarified which metal ions are required for HC·TSG-6 complex formation, identifying divalent cation-binding sites in both IαI and TSG-6 that mediate an initial non-covalent interaction. Furthermore, we have demonstrated that it is the HC transferase activity of TSG-6, rather than HA binding, that is crucial for murine COC expansion.
Experimental Procedures
Production of Recombinant Proteins and HA Oligosaccharides
Full-length human TSG-6 (rhTSG-6) was expressed in Drosophila S2 cells and purified as before (
A novel allelic variant of the human TSG-6 gene encoding an amino acid difference in the CUB module: chromosomal localization, frequency analysis, modeling, and expression.
A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44.
Overexpression, purification and refolding of Link module from human TSG-6 in Escherichia coli: effect of temperature, media and mutagenesis on lysine misincorporation at arginine AGA codons.
). Mutations in CUB_C and rHC1 were introduced into the expression vectors by QuikChange mutagenesis (Agilent Technologies, Cheadle, UK), essentially following the manufacturer's recommendations. Mutations in rhTSG-6 were introduced into the expression vector using the Transformer site-directed mutagenesis kit (Clontech, Palo Alto, CA), following the manufacturer's guidelines (see Refs.
A novel allelic variant of the human TSG-6 gene encoding an amino acid difference in the CUB module: chromosomal localization, frequency analysis, modeling, and expression.
Crystallization of CUB_C and Determination of CUB Module Structure
Initial crystallization conditions were obtained using the SM1 screen from Qiagen (Manchester, UK), using the sitting drop vapor diffusion technique at room temperature. A focused screen around these initial conditions yielded 30-μm crystals with a tetragonal bipyramidal morphology. Seeds derived from these crystals were streaked into drops containing 1 μl of 5 mg/ml CUB_C mixed with 1 μl of mother liquor composed of 100 mm HEPES, pH 7.5, 22% (v/v) PEG 1000, and 200 mm MgSO4, yielding larger crystals.
Data to 2.3 Å were collected from 250 × 250 × 250-μm crystals, cryoprotected using Paratone-N oil (Molecular Dimensions, Cambridge, UK), on a Rigaku-007 rotating anode x-ray generator and an R-axis IV image plate detector. The data were indexed and integrated using the Mosflm program (
). Matthews coefficient analysis indicated the presence of one monomer in the asymmetric unit. Initial phases were obtained by molecular replacement using the Molrep program (
). The molecular replacement solution confirmed P43212 symmetry. This model was then refined to convergence with alternative rounds of restrained maximum likelihood refinement using REFMAC (
). Final processing statistics are shown in Table 1. Only the CUB module (residues 128–249) was visible in the crystal structure with no electron density seen for the last 28 amino acid residues, although this region was verified as present in the crystals by SDS-PAGE (not shown). The last residue observed in the electron density is Pro-249, which protrudes into a large solvent channel; this might allow the C-terminal region to adopt a range of conformations, thus rendering it essentially invisible to crystallography.
TABLE 1Crystallographic data and refinement statistics
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
Analysis of inter-α-trypsin inhibitor and a novel trypsin inhibitor, pre-α-trypsin inhibitor, from human plasma; polypeptide chain stoichiometry and assembly by glycan.
), were incubated together in 20 mm HEPES, pH 7.5, 150 mm NaCl, 5 mm MgCl2 in a total volume of 25 μl for 2 h at 4 °C; this was done either in the absence (“complex formation”) or presence (“HC transfer”) of 40 μg/ml HA14 or bHA10. In complex formation experiments where EGTA/Ca2+ was also added, only 1 mm MgCl2 was used, which is sufficient for full activity (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
); when the pH was varied, sodium acetate (pH 4.0 or 5.0) or MES (pH 6.0 or 6.5) were used instead of HEPES (pH 7.0, 7.5, or 8.0). Samples (7.5 μl of reaction mixture) were then run on 10% (v/v) Tris-Tricine/SDS-polyacrylamide gels after reduction with 5% (v/v) β-mercaptoethanol in SDS protein sample buffer (5 min at 100 °C) and stained with Coomassie Blue. Alternatively, HC·TSG-6 complexes were visualized by Western blotting using a rabbit anti-human polyclonal antibody (RAH-1) raised against TSG-6 (see Ref.
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
) were detected with streptavidin-conjugated Alexa 488 (Invitrogen) on a LI-COR Odyssey system, and band intensities were quantified by ImageJ software. All gels and blots shown are representative of at least three independent experiments.
Surface Plasmon Resonance
Surface plasmon resonance (SPR) experiments were carried out using a BiaCore 3000 or T-200 (GE Healthcare). CUB_C proteins (WT or E183S) and WT rhTSG-6 were coupled to a BiaCore CM5 chip (to give ∼1000 response units) via standard amine-coupling chemistry (EDC-NHS); here CUB_C (50 μg/ml) and WT rhTSG-6 (10 μg/ml) were immobilized in 10 mm sodium acetate, pH 4.0, and 10 mm MES, pH 6.0, respectively, at a flow rate of 10 μl/min. Then rHC1 (WT or D298A) was injected over the chip surface (30 μl/min) at a range of concentrations in 20 mm HEPES, 150 mm NaCl, 0.05% (v/v) Tween 20, pH 7.4 (HBS-T), with/without EDTA (see Table 2); as described above, in the absence of EDTA (“standard” buffer conditions) the “as purified” CUB_C proteins contain Ca2+ ions. In other experiments, rHC1 (WT or D298A) was immobilized on a C1 chip (as described in Ref.
; i.e. at 10 μg/ml in 10 mm sodium acetate, pH 5.5, at 10 μl/min), and Link_TSG6 was flowed over at a range of concentrations in HBS-T. All SPR experiments were performed in duplicate or triplicate, and numerical values (mean ± S.E. in Table 2) were determined from multicycle kinetics, where data were fitted to a 1:1 Langmuir model using the BiaEval T-200 software; fitting of data to a bivalent analyte model did not improve any of the fits.
TABLE 2Surface plasmon resonance analyses and parameters
All values (mean ± S.E.) are based on multicycle kinetics from experiments performed in duplicate (a) or triplicate (b) (analyte at 0–30 nm and 0–300 nm, respectively).
Experiments performed at a single concentration (20 nm) in triplicate.
a,bAll values (mean ± S.E.) are based on multicycle kinetics from experiments performed in duplicate (a) or triplicate (b) (analyte at 0–30 nm and 0–300 nm, respectively).
cExperiments performed at a single concentration (20 nm) in triplicate.
CUB_C protein was incubated in 20 mm HEPES-HCl, 150 mm NaCl, pH 7.4 (HBS) with 10 mm EDTA and 10 mm EGTA before buffer exchange into HBS with 2 μm EDTA and 2 μm EGTA (to remove metal ions and prevent metal ion scavenging, respectively). Intrinsic fluorescence spectra were recorded on 3 μm CUB_C in the absence/presence of 20 μm metal ions on a Jasco (Dunmow, UK) FP750 spectrofluorometer compared with “as purified” CUB_C in HBS alone; the CaCl2, MgCl2, and MnCl2 used (Ultrapure, Sigma-Aldrich) were ultrahigh purity (99.999% (w/w) trace metal basis). The excitation wavelength was set at 280 nm, and emission spectra were recorded between 300 and 400 nm with excitation/emission wavelength slit widths of 4 nm. All measurements were performed in triplicate and averaged after buffer subtraction.
Additionally, the fluorescent intensity of the tryptophan peak at 330 nm was determined (as above) for 2 μm CUB_C in HBS (containing 2 μm EGTA as a metal ion scavenger) at a range of CaCl2 concentrations (0–40 μm). Data were fitted by non-linear regression to a one-site model; the Ca2+ ion concentrations used in the fitting were not corrected to take account of the added EGTA.
Nuclear Magnetic Resonance Spectroscopy
One-dimensional 1H NMR spectra were collected on 0.1 mm CUB_C (WT or E183S) in PBS (pH 6.5) using a Bruker (Coventry, UK) Avance 600-MHz spectrometer (equipped with a 1H-13C/15N TXI cryoprobe with z-gradients) at 25 °C in the absence (“as purified”) or presence of EGTA (5 mm or as indicated) and/or CaCl2 (10 mm).
HA-binding Assay
The HA-binding activity of rhTSG-6 (WT and mutants) was determined using a microtiter-based assay employing biotinylated HA as described previously (
). Briefly, TSG-6 proteins were immobilized at various concentrations on Maxisorb plates (Nunc, Fisher, Loughborough, UK) and incubated with biotinylated HA (12.5 ng/well) in 50 mm sodium acetate, 100 mm NaCl, 0.05% (v/v) Tween 20, pH 6.0; bound biotinylated HA was detected with ExtraAvidin alkaline phosphatase, and plates were developed using disodium p-nitrophenyl phosphate. All absorbance measurements (A405 nm) were corrected by subtracting values from uncoated control wells. Mean data ± S.E. were derived from two independent experiments performed in quadruplicate (n = 8).
COC Expansion Assays
Experiments involving animals were approved by the institutional animal care and use committee and carried out according to the Italian and European rules (D.L. 116/92; EEC Council Directive 86/609; European Directive 2010/63/EU). COC isolation, culture and in vitro expansion were carried out essentially as described before (
Hyaluronan synthesis by mouse cumulus cells is regulated by interactions between follicle-stimulating hormone (or epidermal growth factor) and a soluble oocyte factor (or transforming growth factor β1).
) or wild type (TSG-6+/+) controls were injected with 5 IU of pregnant mares serum gonadotropin (Folligon, MSD Italia, Rome, Italy) and sacrificed 44–48 h later. COCs were isolated from large antral follicles in Eagle's minimum essential medium (Gibco Invitrogen, Milan, Italy) containing 25 mm HEPES, 0.1% (w/v) BSA (Sigma-Aldrich), and 50 ng/ml gentamycin (Gibco Invitrogen). Compact COCs were cultured, under mineral oil (Sigma-Aldrich), in 20-μl droplets of Eagle's minimum essential medium supplemented with 5% (w/v) fetal bovine serum (Gibco Invitrogen), 3 mm glutamine (Sigma-Aldrich), 0.3 mm sodium pyruvate (Sigma-Aldrich), and 50 ng/ml gentamycin in the presence of 3 ng/ml EGF (Life Technologies), at 37 °C with 5% (v/v) CO2 in humidified air for 16 h. TSG-6 proteins were added to the medium at the beginning of culture, at the concentrations indicated in “Results.”
Results
Structure of TSG-6 CUB Module Reveals a Ca2+ Ion-binding Site
To test our prediction that a functionally important metal ion-binding site is present within human TSG-6 (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
), we determined the crystal structure of its CUB module to 2.3 Å (Fig. 1A and Table 1); this was based on the crystallization of the human CUB_C domain (i.e. the CUB module and the C-terminal 29 amino acid residues), which we had previously shown by NMR spectroscopy to be folded (
). This revealed it to have a classical CUB-type jelly roll fold, with a greater degree of similarity to the metal ion-binding subclass of CUB domains (C1s, MASPs) compared with the non-metal ion-binding spermadhesins (
), and, consistent with this, it contained a divalent cation at the site we had predicted (Fig. 1).
FIGURE 1Structure of TSG-6 CUB module.A, cartoon representation of the crystal structure of the CUB module from human TSG-6, colored from blue (N terminus) to red (C-terminus) with the calcium ion in cyan. B, detailed view of the calcium ion-binding site, with ligating residues highlighted. C, side view of TSG-6 CUB module, colored as in A, showing the positions of side chains for Trp-163, Ile-165, Leu-230, and Ile-242. Figures were created using UCSF Chimera.
The metal ion-binding site in the TSG-6 CUB module consists of seven oxygen ligands with pentagonal bipyramidal coordination geometry. This is composed of the main chain carbonyl groups of Ser-234 and Val-235, monodenate coordination with side chain carboxylate groups of Glu-183 and Asp-232, and bidentate coordination with the carboxylate of Asp-191 and a buried water molecule (Fig. 1B), an arrangement highly suggestive of Ca2+ (or perhaps Mn2+). This binding site is very similar to that found in other CUB modules (
), which can be capable of accommodating both Mg2+ and Ca2+ ions. Based on our previous finding that the formation of HC·TSG-6 complexes was dependent on the presence of magnesium ions, we had expected to find a Mg2+ rather than Ca2+ at this site (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
). However, no magnesium ion-binding sites were discovered during the refinement and analysis of the TSG-6 CUB module structure, despite the presence of 200 mm MgSO4 in the crystallization conditions. Analysis of the structure using the “WASP” server (
) confirmed the absence of Mg2+-binding sites in the CUB module structure and confirmed that none of the modeled water molecules were magnesium ions.
Intrinsic fluorescence spectroscopy showed that the addition of 20 μm CaCl2 to metal ion-free CUB_C (3 μm) in physiological salt/pH conditions results in a significant quenching of tryptophan fluorescence at 330 nm, leading to tyrosine fluorescence becoming visible at ∼305 nm (Fig. 2A); because there is only one tryptophan in CUB_C, it can be concluded that Trp-163 (Fig. 1C) is sensitive to Ca2+ ion binding through an altered conformation and/or altered solvent accessibility of the CUB module. Whereas the addition of MgCl2 has essentially no effect on the intrinsic fluorescence spectrum, it can be seen that Mn2+ binds to CUB_C, but the observed change in fluorescence is less pronounced than with CaCl2, indicative of weaker (or differential) binding (Fig. 2A). Non-linear regression analysis of the tryptophan intensities for 2 μm CUB_C at a range of added CaCl2 concentrations (0–40 μm) determined a binding affinity of 1.6 ± 0.6 μm for the interaction of CUB_C with Ca2+ ions (Fig. 2B). In Fig. 2A, the finding that the spectra in the presence of Ca2+ were essentially identical to those collected on the “as purified” CUB_C domain (with no added metal ions or chelators) indicates that following purification, the protein already contains bound calcium.
FIGURE 2The TSG-6 CUB_C domain binds to calcium and manganese ions.A, intrinsic fluorescence spectra of CUB_C in HBS (As purified) or HBS with 2 μm EDTA, 2 μm EGTA in the absence (no M2+) and presence of 20 μm divalent cations; spectra are averaged from three independent experiments after buffer subtraction. B, tryptophan fluorescence intensity values for 2 μm CUB_C (in HBS, 2 μm EGTA) were determined (in triplicate) in the presence of 0–40 μm CaCl2 without subtraction of background fluorescence; these data (mean ± S.D.) were plotted against Ca2+ ion concentration and analyzed by non-linear regression to a one-site binding model (using the formula, fluorescence intensity = Rmin·[Ca2+]/KD·[Ca2+] in GraphPad Prism), yielding a KD value of 1.6 ± 0.6 μm. No errors are shown for the data point at 15 μm Ca2+ because these are within the range covered by the data symbol.
To further explore calcium ion binding, we carried out one-dimensional 1H NMR measurements on CUB_C in different concentrations of EGTA and calcium (Fig. 3). Upon the addition of EGTA to “as purified” CUB_C, there were no major changes in the NMR spectrum, with only subtle alterations observed in the position/intensity of high field-shifted methyl peaks, which were reversed upon the addition of excess Ca2+ ions. Calculations of 1H chemical shifts from the CUB module crystal structure using ShiftX (
) predict that the most high field-shifted resonances correspond to the methyl protons of Ile-165, Leu-230, and Ile-242; of these, Leu-230 is in close proximity to aromatic residues in the vicinity of the Ca2+ ion-binding site, and Ile-165 and Ile-242 are close to Trp-163 that is affected by Ca2+ binding (see Fig. 1C). Overall, these data provide evidence that Ca2+ is not required for stabilization of the TSG-6 CUB module fold but rather plays a role in the local organization of loops surrounding the calcium ion-binding site (see Fig. 1, A and B) and perhaps also has some effect on the stability of the protein core. The similarity of the NMR spectrum for the “as purified” protein to that for CUB_C in the presence of excess Ca2+ ions (Fig. 3) demonstrates that following purification, the CUB_C protein is fully calcium-bound.
FIGURE 3NMR spectra of WT CUB_C in the absence/presence of calcium. One-dimensional 1H NMR spectra were collected for WT CUB_C in the absence (As purified) or presence of added Ca2+ ions and/or EGTA. The black arrows denote the positions of high field-shifted methyl protons that are consistent with a WT fold, where these are perturbed (gray arrows) upon removal of calcium.
Glu-183 in the CUB Ca2+ Ion-binding Site Is Involved in HC·TSG-6 Complex Formation
Two residues of TSG-6 involved in chelating calcium (Glu-183 and Asp-232; Fig. 1B) were mutated in order to determine the role of the Ca2+ ion-binding site in the formation of HC·TSG-6 complexes. E183S and D232A mutants, made in the context of the recombinant full-length protein (rhTSG-6), were found to have greatly diminished ability to form HC·TSG-6 compared with the wild-type (WT) protein based on visualization of this complex on SDS-PAGE (Fig. 4A; data not shown for Asp-232); Western blot analysis revealed a low level of activity for E183S (see lanes 2 and 6 in Fig. 4A for WT and E183S, respectively, under standard assay conditions).
FIGURE 4Structural and functional analyses of WT and E183S TSG-6 in the absence/presence of calcium.A, SDS-PAGE (top) and Western blot (bottom) analyses reveal that E183S mutation severely diminishes HC·TSG-6 complex formation activity of rhTSG-6 and the production of HC·bikunin, which is a by-product of the reaction (see Ref.
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
); the arrowhead indicates the faint HC·TSG-6 band generated with the E183S mutant of TSG-6 in the presence of added Ca2+. The gel/blot shown is representative of three independent experiments. B, one-dimensional 1H NMR spectra of WT and E183S CUB_C in the absence or presence of added Ca2+ ions (10 mm) or EGTA (5 mm). The black and gray arrows show high field-shifted methyl protons as described in the legend to Fig. 3; the spectrum for the “as purified” E183S contains a mixture of these resonances, indicating that in this mutant, the Ca2+-binding site is only partially occupied with metal ions.
Analysis of equivalent mutations in the CUB_C domain by intrinsic fluorescence spectroscopy revealed that alteration of Asp-232 to alanine compromises the folding of the protein (explaining its lack of activity), whereas the E183S mutant remains folded (data not shown). Analysis by NMR confirmed that E183S is folded (Fig. 4B). It also demonstrated that although the E183S and WT proteins have very similar spectra in the presence of EGTA, E183S in the absence of any added EGTA or added Ca2+ (i.e. “as purified”) is a mixture of calcium-bound and calcium-free material. This is indicative of reduced Ca2+ ion-binding affinity for E183S compared with WT CUB_C, which is not surprising given the direct role of Glu-183 in calcium chelation (Fig. 1B). Consistent with this, EGTA treatment effectively abolished HC·TSG-6 complex formation in E183S, whereas WT rhTSG-6 retained some activity (Fig. 4A). Interestingly, in the presence of excess Ca2+ (10 mm), the high field region of the NMR spectrum for E183S closely resembles that of the WT CUB_C domain (Fig. 4B), revealing that under these conditions, it can become fully calcium-bound and attain a fold essentially identical to WT. However, in functional assays, the addition of calcium ions only increased the amount of HC·TSG-6 product formed for E183S to ∼5% of that seen for the WT protein (estimated from SDS-PAGE band intensity; Fig. 4A, lanes 8 and 9). These findings strongly suggest that the side chain of Glu-183 plays an important role in the formation of the covalent complex between TSG-6 and HC that is only partly dependent on its chelation of Ca2+.
Both CUB_C and Link Domains of TSG-6 Interact with IαI HCs
Given the observation that the activity of E183S can be partially restored with excess Ca2+ (Fig. 4A), we reasoned that it is unlikely that this residue has a direct catalytic role in HC·TSG-6 formation but rather that it might participate in substrate (i.e. heavy chain) recognition. In order to test this, we looked at binding of CUB_C to rHC1 using SPR. As shown in Fig. 5A, WT CUB_C interacted with rHC1 in the presence of Ca2+ (KD = 2.1 nm; see Table 2) but did not bind in EDTA; in Fig. 5, pairs of sensorgrams are illustrated at a single common analyte concentration (i.e. for the purposes of easy comparison), where the full SPR data sets are provided in Fig. 6, A–E. Importantly, the E183S mutant had greatly impaired binding to rHC1 (Fig. 5B), providing evidence that this amino acid residue does make a contribution to the non-covalent interaction between TSG-6 and HCs, which is believed to precede formation of the covalent HC·TSG-6 complex (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
D. C. Briggs, C. M. Milner, and A. J. Day, unpublished data.
is unable to bind CUB_C (Table 2). This strongly suggests that metal ion-binding sites in both the CUB module and von Willebrand factor A domains contribute to the interaction between TSG-6 and HCs.
FIGURE 5Metal ion-dependent interaction of TSG-6 with IαI heavy chains is mediated by its CUB_C domain.A–D, comparison of SPR sensorgrams for the interactions of HCs with TSG-6 (WT and mutant proteins in the absence/presence of metal ions); full SPR data sets are provided in Fig. 6 with derived mean numerical values shown in Table 2. A, SPR sensorgrams for interactions of immobilized CUB_C (as purified; i.e. containing Ca2+) with WT rHC1 (20 nm) in the absence or presence of 0.5 mm EDTA. B, SPR sensorgrams for interactions of immobilized CUB_C (WT or E183S) with 50 nm rHC1. C, SPR sensorgrams for interactions of immobilized rHC1 (WT or D298A) with 200 nm Link_TSG6; the concentration of rHC1 was 50 nm compared with 20 nm in A. D, SPR sensorgrams for interactions of immobilized rHC1 (WT) with Link_TSG6 and immobilized rhTSG-6 with rHC1 (D298A); the concentration of Link_TSG6 is 100 nm compared with 200 nm in C. RU, response units.
FIGURE 6SPR analyses of the interactions of rHC1 with TSG-6. SPR sensorgrams (black lines) for the interactions of immobilized WT CUB_C with WT rHC1 (A), immobilized WT (B) and D298A (C) rHC1 with Link_TSG6, and immobilized WT (D) and D298A (E) rHC1 with rhTSG-6; concentrations were 5, 10, 20, 25, and 30 nm for WT rHC1 in A and 18.75, 37.5, 75, 150, and 300 nm for analytes in (B–D). Fits from the Langmuir 1:1 model are shown in red. Data are representative of three independent experiments (see Table 2 for derived numerical values). Despite some apparent biphasic behavior in the interactions, there were no marked improvements in the fits when a bivalent analyte model was applied; moreover, fits with the Langmuir 1:1 model yielded acceptable χ2 values (Table 2), indicating that the derived values represent reasonable estimates of the affinity and kinetics for these interactions. RU, response units.
), which is inconsistent with the above analysis. Therefore, we reasoned that another region of TSG-6 might also contribute to the binding to HCs. SPR with the Link module of TSG-6 (Link_TSG6, which does not have any metal ion binding sites (
)) showed that this domain can interact with rHC1 (both WT and D298A; Figs. 5C and 6 (B and C)), where this had very similar binding kinetics to the interaction of rhTSG-6 with the D298A mutant (Figs. 5D and 6E and Table 2). Thus, we conclude that full-length TSG-6 can interact with HC1 at two distinct sites: a metal ion-independent interaction with the Link domain and a metal ion-dependent interaction with the CUB module.
Free TSG-6 and HC·TSG-6 Utilize Different HA-binding Sites
As noted in the introduction the formation of HC·HA results from the covalent transfer of a HC from the HC·TSG-6 intermediate onto HA (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
). Therefore, it is perhaps not unreasonable to suppose that the HC·TSG-6 complex utilizes the well characterized HA-binding site present in the Link module of TSG-6 (see Ref.
) for its HA recognition during the transfer process. In order to test this hypothesis, we analyzed three rhTSG-6 mutants with impaired HA-binding activity (Fig. 7A) for their ability to form HC·TSG-6 complexes and mediate HC transfer (Fig. 7, B and C); the three mutants have essentially identical intrinsic fluorescence spectra to the WT rhTSG-6 protein in the absence/presence of reducing and/or denaturing buffer (data not shown), which is consistent with NMR spectroscopy on equivalent mutants in the isolated Link module showing that they all had WT folds (
FIGURE 7Determining the role of TSG-6 amino acids in HC·TSG-6 complex formation and HC transfer.A, the HA-binding properties of rhTSG-6 WT and three mutants (Y47F, Y94F, and Y113F) were compared in a microtiter plate-based assay utilizing biotinylated HA (bHA); data are mean values ± S.E. (n = 8). B, SDS-PAGE visualization of HC·TSG-6 complex formation (left) and HC transfer (right) assays for WT rhTSG-6 and three mutants (with impaired HA-binding activities); in the latter, an HA14 oligosaccharide was used as the substrate, leading to the formation of HC·HA14 complexes. The gels shown are each representative of three independent experiments. C, a bHA10 oligosaccharide was used in transfer assays to compare the activities of WT and mutant (Y47F, Y94Y, and E183S) rhTSG-6 proteins, allowing detection of HC·bHA10 complexes on blots (left) made from gels equivalent to those shown in B; bands corresponding to HC·bHA10 were quantitated by densitometry (right) from three independent experiments (mean ± S.E. (error bars)).
As can be seen from Fig. 7, the Y47F, Y94F, and Y113F mutants have reduced HA-binding activities (Fig. 7A), but all retain the ability to form HC·TSG-6 complexes (Fig. 7B). However, whereas Y47F has impaired (but not completely abolished) activity for HC transfer (Fig. 7, B and C), the Y94F and Y113F mutants are indistinguishable from WT rhTSG-6 in their formation of HC·HA (Fig. 7B). This provides clear evidence that the HA interaction site in the context of the HC·TSG-6 intermediate is not the same as the HA-binding site in free TSG-6.
The above data also reveal that the Link module of TSG-6 contributes directly to HC transfer because the Y47F mutant has impaired activity (Fig. 7, B and C). However, the addition of excess Link_TSG6 protein did not affect the formation of HC·TSG-6 or HC·HA complexes (Fig. 8A), demonstrating that the isolated Link module is not an effective competitive inhibitor of HC transfer.
FIGURE 8Role of TSG-6 Link module in HA recognition and pH dependence of complex formation and HC transfer.A, SDS-PAGE analysis of HC transfer assays (with HA14 as substrate) in the presence of different molar ratios of Link_TSG6 to rhTSG-6 (at its standard concentration); the gel shown is representative of three independent experiments. B, SDS-PAGE analysis of HC transfer assays conducted under different pH conditions with HA14 as substrate. These data are representative of three independent experiments.
HC·TSG-6 Complex Formation and HC Transfer Have Different pH Dependences
HC transfer assays conducted at a range of pH values between pH 4.0 and 8.0 revealed that the pH dependences for complex formation and HC transfer onto HA are distinct (Fig. 8B). At pH 6.0, whereas HC·TSG-6 complexes were clearly formed, only very low levels of HC·HA were detectable; neither of these reactions occurred at pH 4.0, and there was only a faint band observed for the HC·TSG-6 complex at pH 5.0. However, at pH 6.5 (and above), complex formation and HC transfer both occur readily. These data indicate that the individual transesterification reactions that lead to the formation of the HC·TSG-6 intermediate and the HC·HA complex are distinct and probably can be uncoupled. Consistent with this, we showed previously that the covalent HC·TSG-6 complex is stable in the absence of HA for relatively long time periods (at least 26 h) but that the second transesterification can proceed once the HA substrate is provided (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
), compact COCs isolated from TSG-6−/− mice were unable to form an expanded and correctly organized cumulus matrix (Fig. 9A) (i.e. when stimulated with epidermal growth factor in vitro and with serum as the source of IαI). However, the inclusion of 1 μg/ml WT rhTSG-6 protein completely rescued this phenotype such that TSG-6−/− COCs expanded in an analogous manner to those from TSG-6+/+ animals (Fig. 9, A and B); the isolated Link module and CUB_C domains were unable to rescue cumulus expansion (Fig. 9A).
FIGURE 9TSG-6 HC transfer activity rather than its HA binding function plays a critical role in cumulus expansion.A, COCs from TSG-6+/+ mice undergo cumulus expansion (over 16 h) when stimulated in vitro with EGF, but TSG-6−/− COCs do not expand, and cumulus cells are shed and settle on the plastic dish. The rhTSG-6 protein (1 μg/ml), but not Link_TSG6 or CUB_C (CUB_C_TSG6) (also both at 1 μg/ml), was able to rescue expansion of TSG-6−/− COCs. These data are representative of two independent experiments. B, expansion of TSG-6−/− COCs was completely rescued by the addition of 1 μg/ml WT or Y94F rhTSG-6. Y47F and E183S only had effects at the highest concentration tested (10 μg/ml), where they mediated partial or complete rescue, respectively. The data shown are representative of three independent experiments.
Mutants of rhTSG-6, with differential activities (Fig. 7), were analyzed in this assay system to determine which functions of TSG-6 are required to support the formation of the cumulus extracellular matrix (Fig. 9B). Like WT rhTSG-6, the Y94F mutant fully rescued COC expansion in a dose-dependent manner, reaching a maximum effect when added at 1 μg/ml (Fig. 9B). This demonstrates that the HA-binding function of TSG-6 is not a major requirement for cumulus expansion because this mutant has greatly impaired HA-binding activity (Fig. 7A) while retaining both WT HC·TSG-6 complex formation and HC transfer activities (Fig. 7, B and C). The E183S mutant, which has impaired (but not abolished) ability to form HC·TSG-6 (Fig. 1C) and HC·HA (Fig. 7C) complexes, was much less active than WT rhTSG-6, only rescuing the TSG-6−/− phenotype when added at 10 μg/ml. The Y47F mutant had lower activity still, only partially rescuing expansion at the highest concentration tested (Fig. 9B); this mutant has defective HA binding and impaired HC transfer activity while retaining the ability to form the HC·TSG-6 complex (Fig. 7). Overall, the above data indicate that TSG-6-mediated formation of HC·HA complexes (via HC·TSG-6 intermediates) is critical for the formation of the cumulus matrix, whereas the HA-binding activity of TSG-6 in the context of the free protein does not contribute greatly to this process.
Discussion
Here, through combined structural and biophysical approaches, we have determined the role of metal ions in the formation of covalent HC·TSG-6 complexes that act as intermediates in HC transfer onto HA. We have also found that although the TSG-6-mediated formation of HC·HA complexes is essential for the expansion of mouse COCs in vitro, the HA-binding function of TSG-6 does not play a major role in the stabilization of the murine cumulus matrix.
As illustrated in Fig. 10, HC·TSG-6 complex formation is a divalent cation-dependent reaction (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
), which our data reveal is mediated by Ca2+, bound to a site within the TSG-6 CUB module. The Glu-183 residue, which is involved in chelating the Ca2+ ion, makes a major contribution to the non-covalent interaction with HCs of IαI (e.g. via their Mg2+-containing MIDAS motifs), which precedes formation of the covalent bond between TSG-6 and HC. Tyr-47 in the Link module of TSG-6 then contributes to HA recognition by the HC·TSG-6 complex during “HC transfer,” but other residues implicated previously in HA binding in free TSG-6 (Tyr-94 and Tyr-113) are not involved in this process.
FIGURE 10Schematic model of the metal ion-dependent interaction of TSG-6 with IαI, leading to the formation of HC·HA complexes via an HC·TSG-6 intermediate.i, the CUB_C domain of TSG-6 interacts via its Glu-183 residue (red space filling) with the MIDAS site (*) of the HCs (illustrated for HC1) in a metal ion-dependent manner, leading to the formation of an initial non-covalent HC·TSG-6 complex. The Glu-183 amino acid conformation (and the surrounding structure) is stabilized by the presence of bound Ca2+, which is essential for the interaction with HCs. ii, the non-covalent HC·TSG-6 complex then converts to a covalent complex via the formation of an ester bond (red) between Ser-28 of TSG-6 (green space filling) and the C-terminal aspartic acid residue of an HC (
). HA is recognized (yellow arrow) by a composite surface involving Tyr-47 of the TSG-6 Link module (pink) and residues of the HC, leading to the covalent transfer of the HC from TSG-6 onto HA. Previous studies have demonstrated that HC transfer is a divalent cation-dependent process (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
), and therefore it is likely to involve the metal ion-dependent interaction in i to stabilize the enzyme complex. iii, formation of HC·HA leads to release of TSG-6 (not shown), which can then interact with a new IαI molecule and catalyze the formation of further HC·HA.
From the results presented here, it is apparent that Ca2+ ion binding is not necessary for the CUB module to fold, but rather it plays a role in providing local structural organization (FIGURE 1, FIGURE 3) (e.g. of surrounding loops). In particular, it probably orients the functionally important Glu-183 amino acid residue, allowing it to interact with the HC. In this regard, our recent crystal studies on human HC1 have revealed that its von Willebrand factor A domain contains a Mg2+-containing MIDAS motif, where mutation of the chelating Asp-298 residue abolishes metal ion binding without having any effect on the overall structure.4 As shown here, the D298A mutant of rHC1 also abolishes binding to the TSG-6 CUB_C domain (Table 2), providing compelling evidence that this Mg2+ ion has a critical function in HC·TSG-6 formation. These findings suggest the intriguing possibility that the metal ion-dependent interaction of TSG-6 with IαI may be mediated by the Glu-183 side chain carboxylate (of the CUB module) co-chelating the magnesium ion within the MIDAS of the HC (i.e. reminiscent of interactions between von Willebrand factor A domains of integrins and their RGD-containing ligands (
The discovery that TSG-6 has a Ca2+ ion-binding site explains why previously we found it unnecessary to add any calcium to form HC·TSG-6 and HC·HA complexes in vitro (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
). This is because the rhTSG-6 used in these assays already contained calcium (i.e. based on “as purified” CUB_C being fully calcium ion-bound) (Fig. 3). Other studies did, however, indicate a requirement of Ca2+ for complex formation and HC transfer (
). In our assay system, the addition of Mg2+ ions is required when we are using preparations of IαI where metal ions have been removed during purification (
). Importantly, differences in the sources of protein reagents and assay conditions probably explain the lack of consistency in the conclusions reached previously on the role of metal ions in the formation of HC·TSG-6 and HC·HA (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
Our interaction analyses described here indicate that the full-length TSG-6 can interact with HC1 at two distinct sites: a metal ion-independent interaction with the Link domain and a metal ion-dependent interaction with the CUB module (Fig. 5). Interestingly, both interactions have Kd values of ∼2 nm (Table 2), which is very similar to the affinity (∼5 nm) for the interaction of rhTSG-6 with rHC1 and rHC2 (
). Therefore, it seems unlikely that simultaneous binding of the CUB and Link modules to HCs can occur (because the affinity for rhTSG-6 would then be considerably higher). In this regard, it is reasonable to suggest that of these it is the CUB-mediated (Ca2+ ion- and Glu-183-dependent) interaction that is critical for HC·TSG-6 complex formation, given the evidence supporting the role of divalent cations (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
) and Glu-183 (FIGURE 1, FIGURE 4A) in this process. On the other hand, the interaction with HC via the TSG-6 Link module might provide a mechanism whereby HC·TSG-6 complexes can remain bound to HC·HA and play a role in further catalysis of HC transfer, as suggested previously (
Characterization of the interaction between tumor necrosis factor-stimulated gene-6 and heparin: implications for the inhibition of plasmin in extracellular matrix microenvironments.
Specificity of the tumor necrosis factor-induced protein 6-mediated heavy chain transfer from the inter-α-inhibitor to hyaluronan: implications for the assembly of the cumulus extracellular matrix.
), can act as weak substrates for HC transfer. At the moment, we do not know the temporal sequence of this CS·bikunin-binding event relative to the metal ion-dependent interaction between the TSG-6 CUB module and an IαI HC (described in the present study). What seems certain is that these interactions are precisely coordinated in such a way as to correctly orient the TSG-6 molecule relative to IαI so that the ester bond connecting an HC to the CS chain can be transferred onto Ser-28 of TSG-6 (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
) suggests a stochastic element to the process. A plausible mechanism would be for an initial Link module-mediated interaction between the TSG-6 and bikunin·CS, followed by a random “molecular collision” between the Glu-183 of the TSG-6 CUB module and the MIDAS of either HC1 or HC2. This would probably lead to a short lived, high affinity, intermediate involving both interactions, which is destabilized once the HC·CS bond has been transferred onto TSG-6 and the bikunin·CS by-product (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
Regardless of the precise sequence of the interactions, the non-covalent HC·TSG-6 complex formed must position the Ser-28 side chain of TSG-6 and the HC·CS ester bond in close proximity to the catalytic site, allowing the covalent HC·TSG-6 complex to form via a transesterification reaction (
). However, currently, we do not know where the enzyme active site is located. Our analyses of the pH dependences of complex formation and HC transfer suggest that a histidine (which usually has pKa values between ∼6.0 and 6.5) is involved in both reactions (Fig. 8B); this functional residue(s) is likely to be present in TSG-6, given its role as the catalyst of HC·HA formation (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
). In this regard, we observed that residues Asp-200 and His-203 of TSG-6 adopt relative conformations reminiscent of Asp-His-Ser catalytic triads within the CUB module structure, and the propKa software (
). However, the H203S mutant of rhTSG-6 was found to have WT activity for HC·TSG-6 complex formation and HC transfer (data not shown), ruling out a role for this amino acid. Systematic mutagenesis will be required to determine whether a histidine residue of TSG-6 does form part of the catalytic site.
Somewhat counterintuitively, we have found that the HA-binding site in “free” TSG-6 is not the same as that used for HA recognition in the context of HC transfer; this was based on a lack of correlation between the abilities of rhTSG-6 mutants to interact with HA and to form HC·HA complexes (Fig. 7). Furthermore, the observation that the Link_TSG6 protein does not inhibit HC·HA formation (Fig. 8A) provided further evidence that the HA-binding site in free TSG-6 is not utilized for HA recognition by HC·TSG-6. This conclusion is consistent with our recent studies showing that there was also no correlation between the substrate activities of various HA oligosaccharides in transfer assays and their affinities for Link_TSG6 (
). Moreover, our previous biophysical experiments have revealed that the interaction of TSG-6 with IαI and the formation of HC·TSG-6 inhibit the binding of TSG-6 to HA, reversing TSG-6-mediated cross-linking of HA (
)) and the similar (greatly reduced) HA-binding phenotype of their phenylalanine mutants (Fig. 7A), they exhibit markedly different contributions to HC transfer activity (Fig. 7, B and C). This could be explained by the formation of a composite HA recognition site involving both TSG-6 and HC within the HC·TSG-6 complex, in which Tyr-47, but not Tyr-94 or Tyr-113, of TSG-6 plays a role (i.e. where HC probably occludes part of the binding surface used for HA in free TSG-6).
Given that HC·TSG-6 (unlike free TSG-6) does not bind tightly to HA (
), it seems plausible that during HC transfer, there is only a transient “interaction” of HA with the active site of this enzyme complex. It seems likely that residues from both TSG-6 and HC contribute to a composite active site (including a histidine, as discussed earlier) that is stabilized by the Glu-183- and Ca2+-dependent interaction of the CUB module with the MIDAS site of the HC (i.e. based on the requirement for divalent cations in the transfer of HC onto HA (
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
)). This active site is probably similar to that used in the initial transesterification reaction (i.e. within the non-covalent HC·TSG-6 complex). However, it is clearly not identical, as can be inferred from the different pH minima of the two reactions (Fig. 8B); this is to be expected because the formation of HC·HA has a different specificity requirement, with the transfer of the ester bond onto the C6 hydroxyl of HA (
Here we have demonstrated that the TSG-6-dependent transfer of HC onto HA is an absolute requirement for the organization/stabilization of the cumulus matrix, whereas the HA-binding properties of TSG-6 do not play an important role (i.e. based on the ability of rhTSG-6 mutants to rescue in vitro expansion of COCs from TSG-6−/− mice) (Fig. 9). These data are consistent with previous studies showing the involvement of HC·HA in COC expansion (
Specificity of the tumor necrosis factor-induced protein 6-mediated heavy chain transfer from the inter-α-inhibitor to hyaluronan: implications for the assembly of the cumulus extracellular matrix.
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
). Furthermore, the present study indicates that TSG-6 is not a major participant in the structural stabilization of the cumulus matrix through its direct cross-linking of HA chains, as has been suggested previously (
Two distinct populations of tumor necrosis factor stimulated gene-6 protein in the extracellular matrix of expanded mouse cumulus-cell oocyte complexes.
). However, this cross-linking process is tightly regulated, and, surprisingly, pentraxin-3 does not integrate into preformed HC·HA films but requires a prior encounter with IαI (
). Why this should be the case is unclear, indicating that there is still much we do not understand regarding how the process of COC expansion is controlled (both temporally and spatially) and the way that these proteins organize HA in the cumulus matrix. In this regard, it seems probable that as well as the association of HC·HA with pentraxin-3, there are likely to be other interactions that play a role in stabilizing the HA network. Interestingly, the finding that the Y47F mutant of rhTSG-6 has the most impaired rescue activity (Fig. 9B), although it retains more HC transfer activity than E183S (Fig. 7C), is indicative that TSG-6 does play an additional role in COC expansion besides its catalysis of HC·HA formation.
This research has provided important new insights into the mechanisms underlying TSG-6-mediated HC·HA formation and has clarified the role of divalent metal ions in this fundamental biological process. It has also identified that it is the transferase activity of TSG-6 that is essential for COC expansion rather than its HA-binding function. These studies therefore provide an excellent basis for additional work to further understand the molecular basis of HA cross-linking during ovulation and inflammation.
Author Contributions
D. C. B. was responsible for protein crystallization, crystallographic data collection, processing and refinement, heavy chain transfer assays, and drafting the paper. H. L. B. performed surface plasmon resonance, intrinsic fluorescence spectroscopy, and CUB_C expression and purification. T. A. carried out CUB_C expression/purification and NMR. M. S. R. conducted mutagenesis of rhTSG-6, heavy chain transfer, and HA-binding assays. J. P. W. aided in NMR data collection, processing, and interpretation. E. I. conducted the in vitro COC expansion assays. T. A. J. co-supervised H. L. B. and aided in fitting/interpretation of SPR data. J. J. E. provided purified IαI protein and contributed to writing of the paper. R. P. R. provided the bHA10 oligosaccharide and contributed to writing of the paper. A. S. supervised the in vitro COC expansion assays and contributed to writing of the paper. C. M. M. co-directed research and contributed to writing of the paper. A. J. D. directed research, supervised experiments, and coordinated writing of the paper.
Acknowledgments
We thank Katalin Mikecz for generously providing TSG-6-deficient mice, Erik Fries for provision of purified IαI used in some of the experiments, and David Knight and Tony Willis for mass spectrometry and amino acid analysis. We also thank Pat Bryant for help with crystallographic data collection and maintenance of local x-ray facilities.
References
Russell D.L.
Salustri A.
Extracellular matrix of the cumulusoocyte complex.
Synthesis and accumulation of hyaluronic acid and proteoglycans in the mouse cumulus cell-oocyte during follicle stimulating hormone-induced mucification.
Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix: a role for a member of the inter-α-trypsin inhibitor family.
Coding sequence, exon-intron structure and chromosomal localization of murine TNF-stimulated gene 6 that is specifically expressed by expanding cumulus cell-oocyte complexes.
Analysis of inter-α-trypsin inhibitor and a novel trypsin inhibitor, pre-α-trypsin inhibitor, from human plasma; polypeptide chain stoichiometry and assembly by glycan.
Organization of the inter-α-inhibitor heavy chains on the chondroitin sulfate originating from Ser10 of bikunin: posttranslational modification of IαI-derived bikunin.
Molecular heterogeneity of the SHAP-hyaluronan complex: isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis.
A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44.
Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
Characterization of the interaction between tumor necrosis factor-stimulated gene-6 and heparin: implications for the inhibition of plasmin in extracellular matrix microenvironments.
Two distinct populations of tumor necrosis factor stimulated gene-6 protein in the extracellular matrix of expanded mouse cumulus-cell oocyte complexes.
41198-6&id=gr1.jpg){kind=link}
41198-6&id=gr2.jpg){kind=link}
41198-6&id=gr3.jpg){kind=link}
41198-6&id=gr4.jpg){kind=link}
41198-6&id=gr5.jpg){kind=link}
41198-6&id=gr6.jpg){kind=link}
41198-6&id=gr7.jpg){kind=link}
41198-6&id=gr8.jpg){kind=link}
41198-6&id=gr9.jpg){kind=link}
41198-6&id=gr10.jpg){kind=link}